stockrowBruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.
- Revenue
- +1.57%
- EPS
- −75.4%
- Free cash flow
- +278.7%
- Total debt
- −14.7%
Quarter to September 2026, against a year earlier
Follow BRKR
Alert me
Bruker Corporation (BRKR) Shares outstanding
Bruker Corporation's shares outstanding at the end of fiscal 2025 was $151.8M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $152.5M. Over the past ten years it has ranged from $147.2M (fiscal 2023) to $169.1M (fiscal 2015); the current reading is higher than 36% of that period. Bruker Corporation ranks 21st of 147 Medical Devices companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $151.8M | 1.54% |
| FY2024 | $149.5M | 1.56% |
| FY2023 | $147.2M | (1.47%) |
| FY2022 | $149.4M | (2.29%) |
| FY2021 | $152.9M | (1.10%) |
| FY2020 | $154.6M | (1.28%) |
| FY2019 | $156.6M | (0.38%) |
| FY2018 | $157.2M | (1.19%) |
| FY2017 | $159.1M | (1.91%) |
| FY2016 | $162.2M | (4.08%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $152.5M | 0.13% |
| Jun 2026 | $152.3M | (0.26%) |
| Mar 2026 | $152.7M | 0.59% |
| Dec 2025 | $151.8M | 0.00% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $449.4M |
| BRKR Bruker Corporation | $152.5M |
| GMED Globus Medical, Inc. compare | $136.0M |
| TXG 10x Genomics compare | $130.0M |
| PODD Insulet Corporation compare | $69.5M |
| GKOS Glaukos Corporation compare | $61.2M |
| PEN Penumbra, Inc. compare | $39.6M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $26.9M |
| BIO Bio-Rad Laboratories, Inc. compare | $26.9M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on BRKR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement